Euglycemic DKA (euDKA) as a presentation of COVID‐19

COVID‐19 in the setting of SGLT2 inhibitor use may precipitate euglycemic DKA separate from known acute viral illness and dehydration precipitants. There should be consideration of proactive discontinuation of these medications in these patients.

Detalles Bibliográficos
Autores principales: Dass, Bhagwan, Beck, Andrew, Holmes, Cody, Morton, Glenville
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753533/
https://www.ncbi.nlm.nih.gov/pubmed/33362928
http://dx.doi.org/10.1002/ccr3.3540
_version_ 1783626052378034176
author Dass, Bhagwan
Beck, Andrew
Holmes, Cody
Morton, Glenville
author_facet Dass, Bhagwan
Beck, Andrew
Holmes, Cody
Morton, Glenville
author_sort Dass, Bhagwan
collection PubMed
description COVID‐19 in the setting of SGLT2 inhibitor use may precipitate euglycemic DKA separate from known acute viral illness and dehydration precipitants. There should be consideration of proactive discontinuation of these medications in these patients.
format Online
Article
Text
id pubmed-7753533
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77535332020-12-22 Euglycemic DKA (euDKA) as a presentation of COVID‐19 Dass, Bhagwan Beck, Andrew Holmes, Cody Morton, Glenville Clin Case Rep Case Reports COVID‐19 in the setting of SGLT2 inhibitor use may precipitate euglycemic DKA separate from known acute viral illness and dehydration precipitants. There should be consideration of proactive discontinuation of these medications in these patients. John Wiley and Sons Inc. 2020-11-20 /pmc/articles/PMC7753533/ /pubmed/33362928 http://dx.doi.org/10.1002/ccr3.3540 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Dass, Bhagwan
Beck, Andrew
Holmes, Cody
Morton, Glenville
Euglycemic DKA (euDKA) as a presentation of COVID‐19
title Euglycemic DKA (euDKA) as a presentation of COVID‐19
title_full Euglycemic DKA (euDKA) as a presentation of COVID‐19
title_fullStr Euglycemic DKA (euDKA) as a presentation of COVID‐19
title_full_unstemmed Euglycemic DKA (euDKA) as a presentation of COVID‐19
title_short Euglycemic DKA (euDKA) as a presentation of COVID‐19
title_sort euglycemic dka (eudka) as a presentation of covid‐19
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753533/
https://www.ncbi.nlm.nih.gov/pubmed/33362928
http://dx.doi.org/10.1002/ccr3.3540
work_keys_str_mv AT dassbhagwan euglycemicdkaeudkaasapresentationofcovid19
AT beckandrew euglycemicdkaeudkaasapresentationofcovid19
AT holmescody euglycemicdkaeudkaasapresentationofcovid19
AT mortonglenville euglycemicdkaeudkaasapresentationofcovid19

Ejemplares similares